{"database": "lobbying", "table": "lobbying_activities", "rows": [[2106734, "759db2ff-8dc4-4c14-b14f-ab205fc21fe4", "Q1", "AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES", 1524, "AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOO", 2018, "first_quarter", "MED", "Sickle Cell Disease Surveillance, Prevention, and Treatment Act of 2018 (H.R. 2410/ S. 2465), which would reauthorize a sickle cell disease prevention and treatment demonstration program and provide for sickle cell disease research, surveillance, prevention, and treatment.", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2018-04-16T15:20:05.653000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2106734"], "units": {}, "query_ms": 0.3641199873527512, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}